|
ALS Beamlines
|
| 5.0.2 |
|
|
| ALS Users |
|
|
|
|
|
|
|
|
|
|
|
|
|
ALS Results
|
|
|
|
|
|
PIs
|
|
ALS Links
|
|
|
| (information on this page from the ALS web site) |
|
The Advanced Light Source (ALS) Overview
|
Location:
Lawrence Berkeley National Laboratory, University of California at Berkeley, in the hills directly above the campus |
Organization:
The Macromolecular Crystallography Facility (MCF) at ALS is a participating research team (PRT) based in the Physical Biosciences Division of the Lawrence Berkeley National Laboratory (LBNL).
The MCF developed and operates the current beamline 5.0.2 as a national user facility for biological crystallography.
A number of future beamlines are being developed by the MCF. Other PRTs are being organized to develop and operate future beamlines as well.
A minimum of 25% of all beamtime will be dedicated to general users.
|
Beamline Properties:
|
|
Beamlines
|
Expt. Methods
|
Energy keV
Wavelength ‰
|
Participating Research Team
|
|
5.0.1
June 2000 |
mono
chromatic |
12.4 keV
(1.0 ‰.) |
Lawrence Berkeley Nat Lab; Amgen; Roche Biosciences;
UC-Berkeley; UC-San Francisco, Genetics Institute,
Lawrence Livermore Nat Lab, NIH |
| 5.0.2 |
MAD |
3.5-14 keV
(0.9-4.0 ‰) |
Lawrence Berkeley Nat Lab; Amgen; Roche Biosciences; UC-Berkeley; UC-San Francisco, Genetics Institute, Lawrence Livermore Nat Lab |
5.0.3
August 2000 |
mono
chromatic |
12.4 keV
(1.0 ‰) |
Novartis Insititute of Functional Genomics |
|
|
Funding:
ALS is operated by the University of California and funded by the U.S. Department of Energy's Office of Basic Energy Sciences. The Macromolecular Crystallography Facility (MCF) is funded principally by the Office of Biological and Environmental Research of the U. S. Department of Energy. |
|
